A Massachusetts woman has joined a group of others across the country in a lawsuit against Utah biotech company Myriad Genetics, claiming the company’s patent on the test for genetic mutations that can cause cancer is unconstitutional. Lisbeth Ceriani was diagnosed with breast cancer and wanted to be tested for a type of gene mutation that can lead to ovarian cancer, but cannot afford it because Myriad Genetics charges so much. The lawsuit claims that the patent impedes research and womens’ access to their own genetic information through testing. The lawsuit also argues that the patents prevent cheaper and more readily available test from being developed.